Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

Myriad Genetics, a leader in genetic testing and precision medicine, has recently announced an exciting update to their MyRisk® with RiskScore® Breast Cancer Risk Assessment. This comprehensive risk model now includes breast density as a key factor, along with personal/family history and genetic markers. By incorporating this additional information, patients and healthcare providers can gain a m..